Follow
Shile Zhang
Shile Zhang
Guardant Health
Verified email at guardanthealth.com
Title
Cited by
Cited by
Year
The microRNA spectrum in 12 body fluids
JA Weber, DH Baxter, S Zhang, DY Huang, K How Huang, M Jen Lee, ...
Clinical chemistry 56 (11), 1733-1741, 2010
31132010
Circulating microRNAs, potential biomarkers for drug-induced liver injury
K Wang, S Zhang, B Marzolf, P Troisch, A Brightman, Z Hu, LE Hood, ...
Proceedings of the National Academy of Sciences 106 (11), 4402-4407, 2009
13772009
Export of microRNAs and microRNA-protective protein by mammalian cells
K Wang, S Zhang, J Weber, D Baxter, DJ Galas
Nucleic acids research 38 (20), 7248-7259, 2010
12462010
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors
JF Shern, L Chen, J Chmielecki, JS Wei, R Patidar, M Rosenberg, ...
Cancer discovery 4 (2), 216-231, 2014
6792014
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
TF Eleveld, DA Oldridge, V Bernard, J Koster, LC Daage, SJ Diskin, ...
Nature genetics 47 (8), 864-871, 2015
5352015
Gene expression networks in COPD: microRNA and mRNA regulation
ME Ezzie, M Crawford, JH Cho, R Orellana, S Zhang, R Gelinas, K Batte, ...
Thorax, thoraxjnl-2011-200089, 2011
3762011
Complexity of the microRNA repertoire revealed by next-generation sequencing
LW Lee, S Zhang, A Etheridge, L Ma, D Martin, D Galas, K Wang
Rna 16 (11), 2170-2180, 2010
3442010
Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
DA Oldridge, AC Wood, N Weichert-Leahey, I Crimmins, R Sussman, ...
Nature, 2015
2982015
Surface plasmon resonance biosensor for rapid label-free detection of microribonucleic acid at subfemtomole level
H Šípová, S Zhang, AM Dudley, D Galas, K Wang, J Homola
Analytical chemistry 82 (24), 10110-10115, 2010
2202010
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
C Krishna, RG DiNatale, F Kuo, RM Srivastava, L Vuong, D Chowell, ...
Cancer Cell 39 (5), 662-677. e6, 2021
1972021
CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus
M Russell, A Penikis, D Oldridge, J Alvarez-Dominguez, L McDaniel, ...
Cancer Resesarch 75 (15), 3155-3166, 2015
1552015
Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes
JH Cho, R Gelinas, K Wang, A Etheridge, MG Piper, K Batte, D Dakhlallah, ...
BMC medical genomics 4 (1), 1-20, 2011
1392011
MultiDimensional ClinOmics for precision therapy of children and adolescent young adults with relapsed and refractory cancer: a report from the center for cancer research
W Chang, AS Brohl, R Patidar, S Sindiri, JF Shern, JS Wei, YK Song, ...
Clinical cancer research 22 (15), 3810-3820, 2016
1072016
Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN-Not-Amplified Human Neuroblastoma
JS Wei, IB Kuznetsov, S Zhang, YK Song, S Asgharzadeh, S Sindiri, ...
Clinical Cancer Research 24 (22), 5673-5684, 2018
1002018
Evidence for a role of vertebrate Disp1 in long-range Shh signaling
LA Etheridge, TQ Crawford, S Zhang, H Roelink
Development 137 (1), 133-140, 2010
762010
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma
D Bogen, JS Wei, DO Azorsa, P Ormanoglu, E Buehler, R Guha, JM Keller, ...
oncotarget 6 (34), 35247-35262, 2015
582015
MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma
S Zhang, J Wei, L Samuel, T Badgett, SK Young, S Agarwal, C Coarfa, ...
Cancer Letters, 2016
532016
Development and validation of an ultra-deep next-generation sequencing assay for testing of plasma cell-free DNA from patients with advanced cancer
Clinical Cancer Research, 2017
502017
Feasibility of monitoring advanced melanoma patients using cell‐free DNA from plasma
TC Gangadhar, SL Savitch, SS Yee, W Xu, AC Huang, S Harmon, ...
Pigment cell & melanoma research 31 (1), 73-81, 2018
282018
HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcome
M Golkaram, ML Salmans, S Kaplan, R Vijayaraghavan, M Martins, ...
NPJ genomic medicine 6 (1), 13, 2021
212021
The system can't perform the operation now. Try again later.
Articles 1–20